2-[3-(2-chloro-4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}phenyl)-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid

This is an extremely complex organic compound with a long and complicated name and is composed of many parts. To know its chemical structure, it is necessary to gradually disassemble and analyze it according to the system naming rules.
First, the main part, "pyridine-4-carboxylic acid" as the root, indicates that this compound has a pyridine ring as the core and a carboxyl group at the 4th position of the pyridine ring.
Look again at the section "2- [3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) -3-hydroxyazacyclobutane-1-yl]". Here, "3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) " means that a specific substituted phenyl group is connected at the 3rd position of a structure, the 2nd position of this phenyl group has a chlorine atom, and the 4th position is connected to a complex oxazole structure through methoxy group. The 5th position of this oxazole structure is connected to cyclopropyl, and the 3rd position is connected to 2,6-dichlorophenyl. " 3-Hydroxyazobutane-1-yl "indicates the presence of an azobutane group containing hydroxyl groups, and this group is connected to the second position of the pyridine ring.
Thus, the chemical structure of this compound is based on pyridine-4-carboxylic acid, and there are hydroxyazobutane groups in the second position of the pyridine ring. This azobutane group is connected with a complex substituted phenyl group, which contains chlorine atoms, methoxy groups, and oxazole structures connected with cyclopropyl and dichlorophenyl groups. Its structure is complex and delicate, and its parts are interconnected to form this unique organic compound.

This is a 2- [3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) -3 -hydroxyazaitane-1-yl] pyridine-4-carboxylic acid, and its physical properties are quite important.
Looking at its properties, this compound is usually a solid, but the specific form may vary slightly due to preparation conditions, either crystalline or powdered. The melting point is one of the important physical parameters, but the exact data is not available, but in general, the melting point of organic compounds can help to identify and determine the purity.
In terms of solubility, because the molecule contains polar carboxyl groups, hydroxyl groups and many aromatic and heterocyclic structures, it may have a certain solubility in polar organic solvents such as dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), and its solubility in water may be limited, because the overall hydrophobicity of the molecule also exists.
In addition, the density of this compound is not easy to determine accurately, and accurate values are not available for the time being. However, it can be speculated from the structure and similar compounds that its density may be similar to that of common organic compounds. Its stability is also crucial. Under normal environmental conditions, without the influence of special chemical reagents or extreme conditions, the structure may be relatively stable. However, due to the chlorine-containing atom and heterocyclic structure, under harsh conditions such as high temperature, strong acid, and strong base, chemical reactions may occur to cause structural changes.

To prepare 2- [3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) -3 -hydroxyazaitane-1-yl] pyridine-4-carboxylic acid, the following method can be followed.
First, a suitable starting material is taken, one of which is a pyridine-4-carboxylic acid-containing structure, and the other is a compound with a target structure fragment that can react with pyridine-4-carboxylic acid. For example, the benzene derivative with suitable substituents and the oxazole derivative containing cyclopropyl and dichlorophenyl are connected through specific steps.
The first step is to use the hydroxyl group or other active group on the benzene derivative to react with the compound containing cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl. Under appropriate catalyst and reaction conditions, such as alkali catalysis, in an organic solvent, the two undergoes a substitution reaction to form an intermediate with an oxazole-containing methoxy phenyl structure.
The second step is to react this intermediate with a compound with a nitrogen-containing heterocyclic butane structure. This reaction may require specific reagents to activate the azacyclobutane moiety so that it can be smoothly connected to the aforementioned intermediates to form a 3-hydroxyazacyclobutane-1-based structure with a hydroxyl group, and this structure is connected to the formed phenyloxazole moiety.
Finally, the resulting product is suitably post-treated, such as purified by extraction, column chromatography, etc., to obtain a high purity of 2- [3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) -3-hydroxyazaheterocyclobutane-1-yl] pyridine-4-carboxylic acid. The reaction conditions at each step need to be carefully controlled. Factors such as the proportion of raw materials, reaction temperature, and reaction time all have an important impact on the reaction process, product yield, and purity. Careful operation is required to achieve good synthesis results.

2-% 5B3-% 282-Chloro-4-% 7B% 5B5-cyclopropyl-3-% 282,6-dichlorophenyl% 29-1,2-oxazole-4-yl% 5D methoxy% 7D phenyl% 29-3-hydroxyazaitane-1-yl% 5D pyridine-4-carboxylic acid, this compound has a wide range of uses in the field of pharmaceutical creation. Its unique chemical structure makes it have diverse biological activities, or can closely bind to specific biological targets and interfere with key physiological processes of cells, so it is used in drug development or as a potential lead compound.
In the development of antibacterial drugs, its structural properties can target specific metabolic pathways or key proteins of bacteria, hinder bacterial growth and reproduction, and achieve antibacterial effects. And because of its complex and unique structure, it can avoid some bacterial resistance mechanisms and is expected to overcome the problem of drug resistance.
In the field of anti-tumor drug research and development, it may be able to target abnormal signaling pathways of tumor cells and bind to specific proteins or receptors to regulate the proliferation and apoptosis process of tumor cells, providing a new direction for the development of anti-tumor drugs.
In the exploration of drugs for the treatment of neurodegenerative diseases, the compound may regulate the activity of related proteins in the nervous system, improve nerve cell function, slow down disease progression, and have potential application value in the treatment of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The practical application of
natural compounds still needs to be verified by a series of rigorous pharmacological, toxicological experiments and clinical trials to clarify their efficacy, safety and pharmacokinetic properties, and to ensure their safe and effective use in clinical treatment.

Nowadays, there are chemical compounds called 2 - [3- (2-chloro-4- {[5-cyclopropyl-3- (2,6-dichlorophenyl) -1,2-oxazole-4-yl] methoxy} phenyl) -3-hydroxyazabutane-1-yl] pyridine-4-carboxylic acid. Looking at its market prospects, this is a complex organic compound with great potential in the field of medicinal chemistry.
In terms of the market, the demand for novel structural compounds in pharmaceutical research and development has been increasing in recent years. The unique structure of this compound may interact with specific biological targets, paving the way for innovative drug development. It is expected to make a name for itself in the research and development of anti-cancer and anti-inflammatory drugs. It contains groups such as chlorine, cyclopropyl and oxazole, which endow it with special physicochemical properties and biological activities.
However, its market front also has challenges. Synthesizing this compound may be difficult and costly, affecting large-scale production and marketing activities. And new drug development requires a long and rigorous trial, from pre-clinical research to clinical trials, and then to approval for marketing, which takes a long time and costs a lot. However, if it can overcome technical challenges, reduce costs, and demonstrate outstanding efficacy and safety in pharmacological research, its market prospects will be promising, or it will become a newcomer in the pharmaceutical market, bringing good news to patients and revolutionizing the pharmaceutical industry.